Pages
Posts by category
- Category: עדכונים
- Category: Article
- Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study (10/01/2023)
- Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study (12/31/2021)
- Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment (10/18/2021)
- Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study (05/20/2021)
- Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment (03/02/2021)
- Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder (02/22/2021)
- Improvements in Workplace Productivity in Working Patients With Major Depressive Disorder: Results From the AtWoRC Study (03/30/2020)
- Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis (01/30/2020)
- Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study (12/30/2019)
- Efficacy of vortioxetine in patients with major depressive disorder reporting childhood or recent trauma (11/13/2019)
- The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder (01/31/2019)
- Efficacy of vortioxetine on the physical symptoms of major depressive disorder (07/26/2018)
- A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder (02/28/2018)
- Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder (09/30/2017)
- Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder (12/09/2016)
- Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis (10/30/2016)
- The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies (02/09/2016)
- Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction (10/30/2015)
- Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study (08/04/2015)
- A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder (08/01/2015)
- A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine (08/04/2014)
- Effect of Vortioxetine on Cardiac Repolarization in Healthy Adult Male Subjects: Results of a Thorough QT/QTc Study (10/30/2013)
- Category: מחקרים ופרסומים
- Category: סרטונים והרצאות